SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-15-005032
Filing Date
2015-06-11
Accepted
2015-06-11 17:10:08
Documents
2
Period of Report
2015-06-10
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A abio-8ka_20150610.htm 8-K/A 30374
2 EX-10.1 abio-ex101_201506107.htm EX-10.1 627913
  Complete submission text file 0001564590-15-005032.txt   659555
Mailing Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020
Business Address 11080 CIRCLEPOINT ROAD SUITE 140 WESTMINSTER CO 80020 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-22873 | Film No.: 15926681
SIC: 2835 In Vitro & In Vivo Diagnostic Substances